Clinical trial
A Phase 3, Placebo-Controlled, Double-Blind Controlled Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster
NCT05480553 is registered in ClinicalTrials.gov with Nobelpharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Placebo-Controlled, Double-Blind Controlled Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster
- Lead sponsor
- Nobelpharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 5, 2022
- Completion date
- August 23, 2023
- Enrollment
- 51 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
acute pain in herpes zoster